Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 18 of 200 found articles
 
 
  4O Nivolumab (NIVO) + ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced NSCLC (aNSCLC) in CheckMate 227 part 1: Efficacy by KRAS, STK11, and KEAP1 mutation status
 
 
Title: 4O Nivolumab (NIVO) + ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced NSCLC (aNSCLC) in CheckMate 227 part 1: Efficacy by KRAS, STK11, and KEAP1 mutation status
Author: Ramalingam, S.S.
Balli, D.
Ciuleanu, T-E.
Pluzanski, A.
Lee, J-S.
Schenker, M.
Bernabe Caro, R.
Lee, K.H.
Bartolucci, R.
Audigier-Valette, C.
Hellmann, M.D.
Paz-Ares, L.G.
Reck, M.
Borghaei, H.
Brahmer, J.R.
O’Byrne, K.
Tran, P.
Spires, T.
Geese, W.J.
Agrawal, S.
Appeared in: Annals of oncology
Paging: Volume 32 () nr. S7 pages S1375-S1376
Year: 2021
Contents:
Publisher: European Society for Medical Oncology
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 18 of 200 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands